BridgeBio Pharma Inc Shares Close the Week 20.8% Higher - Weekly Wrap

The company saw its shares close the week 20.8% higher than last week, with trading volume higher than its 30 day average.

Jun 24, 2022 by Kwhen Finance Editors

BridgeBio Pharma Inc Shares Close the Week 20.8% Higher - Weekly Wrap
BridgeBio Pharma Inc (BBIO) shares closed this week 20.8% higher than it did at the end of last week. The stock is currently down 44.6% year-to-date, down 84.5% over the past 12 months, and down 66.5% over the past five years. This week, the Dow Jones Industrial Average rose 2.5%, and the S&P 500 rose 3.6%.

Trading Activity

  • Shares traded as high as $9.43 and as low as $6.55 this week.
  • Shares closed 85.9% below its 52-week high and 85.5% above its 52-week low.
  • Trading volume this week was 18.6% lower than the 10-day average and 1.8% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
BridgeBio Pharma Inc1.8-44.6-84.5-85.985.1
Dow Jones Industrial Average2.7-14.8-7.8-15.54.3
S&P 500 Index3.2-19.8-9.3-19.95.3
Health Care1.6-9.21.1-10.68.9

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 271.6%
  • The company's stock price performance over the past 12 months lags the peer average by 416.7%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
BridgeBio Pharma IncBBIO-2.3-44.6-84.5-85.985.1
Peer AvgN/A2.1-12.0-16.3-20.56.5
Novartis AG - ADRNVS8.41.0-4.4-11.49.7
Ocuphire Pharma IncOCUP0-49.1-61.0-70.416.3

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: